Risk factors of brain abscess in patients with congenital heart disease.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001922:Brain Abscess / Q000097:blood / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000382:microbiology / Q000401:mortality / Q000517:prevention & control / Q000601:surgery / Q000628:therapy; D004562:Electrocardiography; D005500:Follow-Up Studies; D006330:Heart Defects, Congenital / Q000150:complications* / Q000601:surgery; D006339:Heart Rate; D006345:Heart Septal Defects, Ventricular / Q000150:complications; D006400:Hematocrit; D006454:Hemoglobins; D006801:Humans; D009461:Neurologic Manifestations; D010100:Oxygen / Q000097:blood; D013771:Tetralogy of Fallot / Q000150:complications; D014188:Transposition of Great Vessels / Q000150:complications
D000900:Anti-Bacterial Agents; D006454:Hemoglobins; D010100:Oxygen